Plant-based Excipients Market By Product Type (Binders {Starch, Cellulose Pectin, Guar Gum}, Fillers & Diluents {Microcrystalline Cellulose, Lactose Alternatives}, Disintegrants {Alginates, Natural Gums}, Lubricants {Stearic Acid}, Coating Agents {Shellac Alternatives}, Emulsifiers & Stabilizers {Lecithin, Xanthan Gum}), By Source (Starch-Based, Cellulose-Based, Gum-Based, Others), By Dosage Form (Tablets, Capsules, Powders, Liquid Formulations, Topical & Semisolid Forms) By End-user (Pharmaceutical Companies, Nutraceutical Manufacturers, Cosmetic & Personal Care Industry, Food & Beverage Industry, Contract Manufacturing Organizations), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Plant-based Excipients Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Rising demand for natural and clean-label ingredients in pharmaceutical formulations.

3.2.2. Growing vegan population and consumer preference for plant-derived excipient alternatives.

3.2.3. Enhanced regulatory support for naturally sourced and biocompatible pharmaceutical excipients.

3.3. Key industry pitfalls & challenges

3.3.1. Limited functional diversity and compatibility compared to synthetic excipients in formulations.

3.3.2. High production and extraction costs associated with plant-based excipients.

3.3.3. Variability in raw material quality affecting batch-to-batch consistency.

3.4. Market Opportunities

3.4.1. Increasing R&D in multifunctional plant-derived excipients with improved formulation performance.

3.4.2. Expansion in emerging markets with growing herbal and ayurvedic medicine adoption.

3.4.3. Collaborations for sustainable sourcing and green excipient production technologies.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Plant-based Excipients Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Binders

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Starch

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Cellulose Pectin

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. Guar gum

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Fillers & Diluents

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Microcrystalline cellulose

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Lactose alternatives

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Disintegrants

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Alginates

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Natural gums

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Lubricants

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5.2. Stearic acid

4.5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Coating Agents

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6.2. Shellac alternatives

4.6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Emulsifiers & Stabilizers

4.7.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7.2. Lecithin

4.7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7.3. Xanthan gum

4.7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Plant-based Excipients Market, Source Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Source, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Starch-based

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Cellulose-based

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Gum-based

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Others

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Plant-based Excipients Market, Dosage Form Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Dosage Form, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Tablets

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Capsules

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Powders

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Liquid Formulations

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Topical & Semisolid Forms

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Plant-based Excipients Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Pharmaceutical Companies

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Nutraceutical Manufacturers

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Cosmetic & Personal Care Industry

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Food & Beverage Industry

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Contract Manufacturing Organizations (CMOs)

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Plant-based Excipients Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Source, 2025-2035

8.2.4. North America Market Revenue, By Dosage Form, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Source, 2025-2035

8.2.6.3. U.S. Market Revenue, By Dosage Form, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Source, 2025-2035

8.2.7.3. Canada Market Revenue, By Dosage Form, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Product Type, 2025-2035

8.3.3. Europe Market Revenue, By Source, 2025-2035

8.3.4. Europe Market Revenue, By Dosage Form, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Source, 2025-2035

8.3.6.3. Germany Market Revenue, By Dosage Form, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Product Type, 2025-2035

8.3.7.2. France Market Revenue, By Source, 2025-2035

8.3.7.3. France Market Revenue, By Dosage Form, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Source, 2025-2035

8.3.8.3. U.K. Market Revenue, By Dosage Form, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Source, 2025-2035

8.3.9.3. Italy Market Revenue, By Dosage Form, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Source, 2025-2035

8.3.10.3. Spain Market Revenue, By Dosage Form, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Source, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Dosage Form, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Source, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Dosage Form, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Product Type, 2025-2035

8.4.6.2. China Market Revenue, By Source, 2025-2035

8.4.6.3. China Market Revenue, By Dosage Form, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Source, 2025-2035

8.4.7.3. Japan Market Revenue, By Dosage Form, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Product Type, 2025-2035

8.4.8.2. India Market Revenue, By Source, 2025-2035

8.4.8.3. India Market Revenue, By Dosage Form, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Source, 2025-2035

8.4.9.3. Australia Market Revenue, By Dosage Form, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Source, 2025-2035

8.4.10.3. South Korea Market Revenue, By Dosage Form, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Source, 2025-2035

8.4.11.3. Singapore Market Revenue, By Dosage Form, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Source, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Dosage Form, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Product Type, 2025-2035

8.5.3. Latin America Market Revenue, By Source, 2025-2035

8.5.4. Latin America Market Revenue, By Dosage Form, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Source, 2025-2035

8.5.6.3. Brazil Market Revenue, By Dosage Form, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Source, 2025-2035

8.5.7.3. Argentina Market Revenue, By Dosage Form, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Source, 2025-2035

8.5.8.3. Mexico Market Revenue, By Dosage Form, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Source, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Dosage Form, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Product Type, 2025-2035

8.6.3. MEA Market Revenue, By Source, 2025-2035

8.6.4. MEA Market Revenue, By Dosage Form, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Source, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Dosage Form, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Source, 2025-2035

8.6.7.3. South Africa Market Revenue, By Dosage Form, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Source, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Dosage Form, 2025-2035

8.6.8.4. Rest of Middle East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. DuPont de Nemours, Inc.

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Roquette Frères

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Ashland Global Holdings Inc.

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Ingredion Incorporated

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Kerry Group plc

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. BASF SE

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Cargill, Incorporated

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. The Lubrizol Corporation

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Evonik Industries AG

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. DFE Pharma

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. FMC Corporation

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Colorcon Inc.

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. Gattefossé Group

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. MEGGLE GmbH & Co. KG

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. JRS Pharma

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis